The history of the erectile dysfunction drug presents a complex picture for investors. While the initial introduction generated substantial gains, the lapse of its patent opened the floodgates to generic competitors, https://orangebookmarks.com/story21699460/the-copyright-and-the-pharmaceutical-industry-a-volatile-bet